Boston Scientific Corp

NYSE:BSX  
42.25
-0.39 (-0.91%)

People also watch

StockTwits Share  Twitter Share  Facebook Share
Market Cap (Intraday)58.22B
Current PE32.38
Forward PE 27.08
2yr Forward PE N/A
See more stats...
Estimates Current Quarter
Revenue$2.64 Billion
Adjusted EPS$0.38
See more estimates...
10-Day MA$42.38
50-Day MA$40.45
200-Day MA$37.99
See more pivots...

BOSTON SCIENTIFIC CORP Stock, NYSE:BSX

300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA 01752-1234
United States of America
Phone: 508-683-4000
Number of Employees: 27000

Description

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg. The company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; other coronary therapy products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels; and structural heart therapy systems. It also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters used to treat peripheral arterial disease; and biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease benign and malignant tumors. In addition, the company offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; implantable cardiac resynchronization therapy pacemaker systems used to treat heart failure; and medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising steerable radio frequency ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Further, it provides products to diagnose and treat diseases of the pulmonary and gastrointestinal conditions; devices to diagnose, treat, and ease pulmonary disease systems within the airway and lungs; products to treat urinary stone disease and benign prostatic hyperplasia; mid-urethral sling products, sling and graft materials, pelvic floor reconstruction kits, and suturing devices; and spinal cord stimulator systems for the management of chronic pain. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.